|
Photo: Daily Mail |
British MS patients have waited 11 years for Sativex, a cannabis-based oral spray. Now many of them still won’t get it. |
Doctors in southern England have been told not to prescribe a new cannabis-based drug developed for multiple sclerosis patients, reports the BBC.
Sativex, an oral spray which had taken 11 years to develop, was licensed for medical use in the United Kingdom last week.
But unaccountably, 10 primary care trusts have told physicians not to give the treatment, which is designed to reduce pain, claiming it is not effective.
The MS Society charity called the decision “arbitrary and disappointing” and said it would fight against it. It said the decision could affect hundreds of patients.